Downregulation of LPR1 at the blood–brain barrier in streptozotocin-induced diabetic mice

Deposition of amyloid-β peptide (Aβ) in the diabetic brain is poorly understood. Low-density lipoprotein receptor related protein 1(LRP1) at the blood–brain barrier (BBB) is critical for regulation of Aβ homeostasis in the brain. In this study, we used streptozotocin-induced diabetic mice to observe...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neuropharmacology 2009-05, Vol.56 (6), p.1054-1059
Hauptverfasser: Hong, Hao, Liu, Li Ping, Liao, Jian Ming, Wang, Tong Sheng, Ye, Feng Ying, Wu, Jing, Wang, Ying Yu, Wang, Ying, Li, Yong Qi, Long, Yan, Xia, Yuan Zheng
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Deposition of amyloid-β peptide (Aβ) in the diabetic brain is poorly understood. Low-density lipoprotein receptor related protein 1(LRP1) at the blood–brain barrier (BBB) is critical for regulation of Aβ homeostasis in the brain. In this study, we used streptozotocin-induced diabetic mice to observe the expression of LRP1 at the BBB by Western blot and immunocytochemical analysis, and to study in vivo brain-to-blood efflux transport of 125I-Aβ1–40 using brain clearance studies. In the diabetic mice with hyperglycemia (>16.0 mmol/l) at 6 weeks, LRP1 expression at the BBB was significantly downregulated; no significant changes of LRP1 levels were found at 1 and 3 weeks after diabetes induction. The data of brain clearance studies for Aβ showed significant decrease in LRP1-dependent transport of Aβ across the BBB at 6 weeks after diabetes induction, while no significant changes of LRP1-dependent transport of Aβ across the BBB at 1 or 3 weeks after diabetes induction were apparent. We conclude that the downregulation of LRP1 at the BBB contributes to cerebral Aβ deposition in diabetes mellitus.
ISSN:0028-3908
1873-7064
DOI:10.1016/j.neuropharm.2009.03.001